ID |
IPI |
Description |
Subcellular localization |
Protein abundance and peptides identification |
GroSize |
ProGroup |
PM |
Cyto |
Mito |
rER |
sER |
Nucl |
4261 |
IPI00646058.2 |
Scaffold attachment factor B |
Nucl(G1) |
- |
- |
- |
- |
- |
3.47E-01 (AIEDEGGNPDEIEITSEGNKK;LAEEEDLFDSAHPEEGDLDLASESTAHAQSSK;SEPVKEESSELEQPFAQDTSSVGPDR;SEPVKEESSELEQPFAQDTSSVGPDRK;KFDFDACNEVPPAPK;KLAEEEDLFDSAHPEEGDLDLASESTAHAQSSK;NFWVSGLSSTTR;ELPEQLQEHAIEDK) |
2 |
IPI00300631.3, IPI00646058.2
|
4262 |
IPI00646062.3 |
Kelch domain-containing protein 8A |
Cyto(G2) |
- |
- |
- |
3.53E-02 (YAVNAFEVFDIETRSWTK;AGVAVTALGK) |
- |
- |
1 |
IPI00646062.3
|
4263 |
IPI00646304.4 |
Peptidylprolyl isomerase B precursor |
ER(SP) |
6.14E+00 (DTNGSQFFITTVK;IEVEKPFAIAK;IEVEKPFAIAKE;VLEGMEVVR;DFMIQGGDFTR;TVDNFVALATGEK;VIFGLFGK) |
5.56E-01 (DTNGSQFFITTVK;IEVEKPFAIAK;IEVEKPFAIAKE;DKPLKDVIIADCGK;VIKDFMIQGGDFTR;FPDENFK;TVDNFVALATGEK;VIFGLFGK) |
- |
4.14E+01 (DFMIQGGDFTR;DTNGSQFFITTVK;FPDENFK;HVVFGKVLEGMEVVR;HYGPGWVSMANAGK;IEVEKPFAIAK;IEVEKPFAIAKE;SIYGERFPDENFK;VIKDFMIQGGDFTR;VLEGMEVVR;IGDEDVGRVIFGLFGK;TVDNFVALATGEK;TVDNFVALATGEKGFGYK;VIFGLFGK;VY |
1.72E+01 (DFMIQGGDFTR;DTNGSQFFITTVK;DTNGSQFFITTVKTAWLDGKHVVFGK;FPDENFK;HYGPGWVSMANAGK;IEVEKPFAIAK;IEVEKPFAIAKE;VIKDFMIQGGDFTR;VLEGMEVVR;IGDEDVGRVIFGLFGK;TVDNFVALATGEK;VIFGLFGK;VYFDLR) |
2.71E+00 (DTNGSQFFITTVK;IEVEKPFAIAK;IEVEKPFAIAKE;DKPLKDVIIADCGK;FPDENFK;TVDNFVALATGEK;VIFGLFGK) |
1 |
IPI00646304.4
|
4264 |
IPI00646318.2 |
CYP4A11 protein |
ER(SP,GO) |
- |
6.45E-02 (ACQLAHQHTDQVIQLR;HLDFLDILLLAK;NSQSYIQAISDLNNLVFSR;NAFHQNDTIYSLTSAGR) |
2.28E-01 (ACQLAHQHTDQVIQLR;ELSTPVTFPDGR;NAFHQNDTIYSLTSAGR;NSQSYIQAISDLNNLVFSR) |
- |
- |
5.87E-01 (ALQQFPCPPSHWLFGHIQELQQDQELQR;ACQLAHQHTDQVIQLR;HLDFLDILLLAK;NAFHQNDTIYSLTSAGR;NSQSYIQAISDLNNLVFSR;ELSTPVTFPDGR) |
1 |
IPI00646318.2
|
4265 |
IPI00646323.1 |
Novel protein |
PM(G2) |
- |
1.50E-02 (LSIVDDEATLNGMGLVIAQALSEYNR;ELVRSISTNVRR) |
- |
2.11E-02 (VTHALVNIR;EHGYDAVVLLALLVNYR) |
- |
- |
1 |
IPI00646323.1
|
4266 |
IPI00646350.2 |
61 kDa protein |
Cyto(G2) |
- |
7.84E-02 (EHPVIESHPDNALEDLR;LLQSIGQAPESISEK;NENGAPEDEENFEEAIK;FTVVVATQLPESTSLR;LADVLWNSQIPLLICR;YPGVSNYQVEEDIGK;YGAAEPHTIAAFLGGAAAQEVIK) |
- |
- |
- |
- |
5 |
IPI00018968.2, IPI00479845.3, IPI00604652.1, IPI00604676.1, IPI00646350.2
|
4267 |
IPI00646351.1 |
arginine-rich, mutated in early stage tumors-like 1 |
ER(G1) |
- |
- |
- |
2.68E-01 (GVNFSLDTIEK;TDYVNLIQELAPK;TLDLASVDLR) |
1.08E-01 (TDYVNLIQELAPK;TLDLASVDLR) |
- |
1 |
IPI00646351.1
|
4268 |
IPI00646361.2 |
KIAA0023 protein |
Nucl(SP,GO); Cyto(GO) |
- |
- |
- |
- |
- |
2.05E-02 (TSGVPSGFNFTAPPVLGK;LGELLFPSSLAGETLGSFSGLR;TTLLEGFAGVEEAR) |
3 |
IPI00183294.3, IPI00465191.3, IPI00646361.2
|
4269 |
IPI00646377.1 |
Isoform 1 of Eukaryotic translation initiation factor 4 gamma 3 |
Nucl(G1) |
1.31E-02 (ELQALYALQASIVK;FLKITKPTIDEK) |
- |
- |
- |
- |
1.50E-02 (FLKITKPTIDEK;PEGLPPISDVVLDK) |
2 |
IPI00328268.8, IPI00646377.1
|
4270 |
IPI00646493.1 |
COPA protein |
Cyto(G1,GO) |
- |
3.41E-01 (CPLSGACYSPEFK;DMSGHYQNALYLGDVSER;FPVFNMSYNPAENAVLLCTR;GFFEGTIASK;GTSPTQIWCNNSQLPVDHILAGSFETAMR;GYPEVALHFVKDEK;LGEVALLQGNHQIVEMCYQR;LLQPPAPIMPLDTNWPLLTVSK;LSFLYLITGNLEK;LVGQSIIAYLQK;NPTDAYQLN |
- |
3.85E-02 (LSFLYLITGNLEK;SILLSVPLLVVDNK;LVGQSIIAYLQK;NLSPGAVESDVR) |
3.62E-02 (DADSITLFDVQQK;SILLSVPLLVVDNK;SGAWDESGVFIYTTSNHIK;LSFLYLITGNLEK;LVGQSIIAYLQK) |
- |
1 |
IPI00646493.1
|
4271 |
IPI00646500.1 |
Isoform 3 of Replication protein A 32 kDa subunit |
Nucl(SP,GO,HPA) |
- |
6.88E-02 (ACPRPEGLNFQDLK;QAVDFLSNEGHIYSTVDDDHFK;AQHIVPCTISQLLSATLVDEVFR;IGNVEISQVTIVGIIR) |
- |
- |
- |
- |
3 |
IPI00013939.3, IPI00646500.1, IPI00647667.1
|
4272 |
IPI00646572.1 |
1518 kDa protein |
Nucl(G2) |
- |
- |
- |
2.96E-03 (DSLYLNGYNEPGPDEPPTTPK;ATSSITTGTPEISTK;LDTSHLPIGTTASSETSMDFTMAK) |
- |
- |
1 |
IPI00646572.1
|
4273 |
IPI00646625.1 |
transporter 1, ATP-binding cassette, sub-family B |
ER(SP) |
- |
- |
- |
2.43E-02 (SVLLITQHLSLVEQADHILFLEGGAIR;MAELLASAGSACSWDFPR) |
- |
- |
1 |
IPI00646625.1
|
4274 |
IPI00646689.1 |
Thioredoxin-like protein 5 |
Cyto(SP,GO) |
- |
6.55E-02 (YEEVSVSGFEEFHR;SWCPDCVQAEPVVR) |
- |
- |
- |
- |
2 |
IPI00646689.1, IPI00797323.1
|
4275 |
IPI00646708.1 |
65 kDa protein |
PM(G2) |
- |
- |
- |
2.77E-02 (SLPISLVFLVPVR;TQVTFFFPLDLSYR;YAVYMVVTSHGVSTK;STFINMTRVDSDMNDAYLDR) |
- |
- |
1 |
IPI00646708.1
|
4276 |
IPI00646748.1 |
Tropomyosin 2 |
Cyto(G2) |
- |
3.79E-02 (ATDAEADVASLNR;IQLVEEELDR;RIQLVEEELDR;LVILEGELER;KLVILEGELER;CGDLEEELK) |
- |
- |
5.01E-02 (IQLVEEELDR;RIQLVEEELDR;TIDDLEETLASAK) |
- |
1 |
IPI00646748.1
|
4277 |
IPI00646762.1 |
26 kDa protein |
Cyto(G1) |
- |
2.83E+00 (EQTADGVAVIPVLQR;PGDGEFVEVISLPK;PKPGDGEFVEVISLPK;QFRPPMGGYCIEFPAGLIDDGETPEAAALR;QYIISEELISEGK;KEQTADGVAVIPVLQR;PKPKPGDGEFVEVISLPK;TLHYECIVLVK;HANAKPFEVPFLK;LDALVAEEHLTVDAR;VYSYALALK;PFEVPFLK) |
- |
- |
1.12E-01 (HANAKPFEVPFLK;PKPGDGEFVEVISLPK;EQTADGVAVIPVLQR) |
- |
2 |
IPI00296913.1, IPI00646762.1
|
4278 |
IPI00646779.2 |
TUBB6 protein |
ER(G1) |
2.15E-01 (FPGQLNADLR;GHYTEGAELVDSVLDVVR;LAVNMVPFPR;NSSYFVEWIPNNVK;MASTFIGNSTAIQELFK;ALTVPELTQQMFDAK) |
- |
- |
2.30E-01 (FPGQLNADLR;GHYTEGAELVDSVLDVVR;LAVNMVPFPR;NSSYFVEWIPNNVK;MASTFIGNSTAIQELFK;ALTVPELTQQMFDAK) |
3.43E-01 (FPGQLNADLR;GHYTEGAELVDSVLDVVR;LAVNMVPFPR;NSSYFVEWIPNNVK;MASTFIGNSTAIQELFK;ALTVPELTQQMFDAK) |
- |
1 |
IPI00646779.2
|
4279 |
IPI00646822.1 |
HLA class I histocompatibility antigen, alpha chain F precursor |
Nucl(G1); PM(GO) |
- |
- |
- |
- |
- |
5.85E-02 (WAAVVVPSGEEQR;FYEAEEYAEEFR;GSYSQAAVTDSAQGSGVSLTANKV) |
1 |
IPI00646822.1
|
4280 |
IPI00646839.1 |
similar to eukaryotic translation initiation factor 3, subunit 8, 110kDa isoform 1 |
Cyto(G2) |
- |
8.35E-02 (DAHNALLDIQSSGR;AAQIELLQLLVQIAAENNLGEGVIVK;DLMLMSHLQDNIQHADPPVQILYNR;TMVQLGICAFR;LNEILQAR;GCILTLVER;TEPTAQQNLALQLAEK) |
- |
2.08E-02 (TEPTAQQNLALQLAEK;DAHNALLDIQSSGR) |
- |
- |
2 |
IPI00016910.1, IPI00646839.1
|
4281 |
IPI00646871.2 |
Chromodomain helicase DNA binding protein 5 |
Nucl(G2) |
- |
5.49E-03 (AYVSLFMR;EGPGLGARRAR) |
- |
- |
- |
- |
1 |
IPI00646871.2
|
4282 |
IPI00646899.1 |
Ribosomal protein L10 |
Cyto(G2) |
- |
5.19E-02 (VDEFPLCGHMVSDEYEQLSSEALEAAR;IFDLGR;VHIGQVIMSIR;AKVDEFPLCGHMVSDEYEQLSSEALEAAR) |
- |
1.10E-01 (FNADEFEDMVAEK;FNADEFEDMVAEKR) |
7.88E-02 (FNADEFEDMVAEK;VHIGQVIMSIR) |
- |
3 |
IPI00374260.4, IPI00554723.3, IPI00646899.1
|
4283 |
IPI00646917.1 |
Cleavage and polyadenylation specificity factor 5 |
Nucl(SP,GO) |
- |
1.38E-01 (LPGGELNPGEDEVEGLKR;LVAAPLFELYDNAPGYGPIISSLPQLLSR;YIQQTKPLTLER;TVEGVLIVHEHR;LPHVLLLQLGTTFFK) |
5.98E-01 (LPGGELNPGEDEVEGLK;LPGGELNPGEDEVEGLKR;LVAAPLFELYDNAPGYGPIISSLPQLLSR;PNFEPPQYPYIPAHITKPK;LPHVLLLQLGTTFFK;TINLYPLTNYTFGTK;TVEGVLIVHEHR;YIQQTKPLTLER) |
5.55E-02 (LPHVLLLQLGTTFFK;TINLYPLTNYTFGTK) |
- |
3.68E+00 (KLFLVQLQEK;LFLVQLQEK;LPGGELNPGEDEVEGLK;LPGGELNPGEDEVEGLKR;LVAAPLFELYDNAPGYGPIISSLPQLLSR;NYKLVAAPLFELYDNAPGYGPIISSLPQLLSR;YIQQTKPLTLER;LPHVLLLQLGTTFFK;PNFEPPQYPYIPAHITKPK;TINLYPLTNYTFGTK;TVEG |
1 |
IPI00646917.1
|
4284 |
IPI00646942.2 |
IMP dehydrogenase/GMP reductase family protein |
Cyto(G2); PM(G2) |
- |
- |
1.73E-02 (VLLPPLWNR;QLFTKPHPAR;IQEQLFGELGLWSQGEETK) |
- |
- |
- |
1 |
IPI00646942.2
|
4285 |
IPI00646963.2 |
23 kDa protein |
ER(G1) |
1.98E+00 (ALDAAAGITR;NLVTEVLGALEAK;QRVEHFLEQR;VVRPLFLR) |
2.91E-01 (NLVTEVLGALEAK;NLVTEVLGALEAKTGVEK;VVRPLFLR;QRVEHFLEQR) |
- |
2.58E+00 (NLVTEVLGALEAK;PWNGALMLYQR;QRVEHFLEQR;VVRPLFLR;ALDAAAGITR) |
1.04E+00 (NLVTEVLGALEAK;IMNDLSGRALDAAAGITR;VVRPLFLR;AGITPVAVAGPSTPLEADLKPSQTPQPK) |
- |
1 |
IPI00646963.2
|
4286 |
IPI00647008.1 |
Isoform 2 of Bromodomain-containing protein 7 |
Nucl(SP,GO); Cyto(GO) |
- |
1.43E-02 (QSIDFMADLQKTR;NNDYQSIEELKDNFK) |
- |
- |
- |
3.87E-02 (AVTNFGVPVEVFDSEEAEIFQK;NNDYQSIEELKDNFK) |
2 |
IPI00001707.4, IPI00647008.1
|
4287 |
IPI00647124.1 |
A1 chain of type XIX collagen |
Nucl(G2) |
- |
- |
- |
1.82E-02 (DNKGNDEHEAGGLK;MLNPISNVSFR) |
- |
- |
1 |
IPI00647124.1
|
4288 |
IPI00647205.1 |
hypothetical protein LOC387104 |
Nucl(G2) |
1.90E-02 (INAQMKAFR;QQQLQQQQQQGNKTGSR) |
- |
- |
- |
- |
- |
1 |
IPI00647205.1
|
4289 |
IPI00647207.3 |
FHL1 protein |
Cyto(G2,SP,GO); PM(GO); Nucl(SP) |
- |
7.12E-02 (AIVAGDQNVEYK;FCANTCVECR;FVFHQEQVYCPDCAK;FTAVEDQYYCVDCYK) |
- |
- |
- |
- |
2 |
IPI00014398.2, IPI00647207.3
|
4290 |
IPI00647217.2 |
Superkiller viralicidic activity 2-like 2 |
Nucl(SP,HPA) |
- |
2.12E-02 (SNVKPNSGELDPLYVVEVLLR;TVCAEYAIALALREKQR) |
- |
1.20E-02 (VEEINPEYMLEKSFYQFQHYR;VEEINPEYMLEK) |
- |
3.06E-02 (SNVKPNSGELDPLYVVEVLLR;SFYQFQHYR;GIGIHHGGLLPILK;DVDFEGTDEPIFGK) |
1 |
IPI00647217.2
|